List of Equipment Companies in United Kingdom - 18

Our mission at Abselion is to simplify protein quantification for the scientists making crucial decisions to accelerate the development of biotherapeutics. Our tools help researchers to develop the medicine of the future and to find the best ways to produce new biomolecules. We focus on convenient tools with high degree of automation and low hands-on time to accelerate access to actionable data. Our award-winning Amperia system, built on proprietary Redox Electrochemical Detection (RED) technology, brings a new approach to biologics and viral-vector quantification for confident and cost-effective automated, at-line titre measurement, at any bench or bioreactor. By enabling agile and straightforward access to titre data, we empower scientists to focus on the decisions that can drive bioprocess optimisation and innovation. We are a dynamic, interdisciplinary team working at the intersection of biology, nanotechnology and data science. We value a flat hierarchy, where everyone is encouraged to share their ideas and to follow their passion.

We are a UK-based company specialising in manufacturing and worldwide supply of consumables, equipment, and services to the cellular pathology sector. The CellPath name is synonymous with innovative, precise and well-proven products manufactured to a very high standard. We have a state-of-the-art injection moulding capability at our headquarters in Wales, allowing us to differentiate ourselves in the marketplace by directly manufacturing many of the plastic products used in modern histology and cytology laboratories. Expansion and infrastructure investment over recent years have increased our manufacturing capability, allowing us to introduce additional products to the market such as chemicals, stains, tissue marking dyes and fixatives. CellPath has a continuous improvement process built around a strong desire to maintain a high level of quality, and we are currently certified to ISO 13485:2016 standards.

CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale. CellVoyant is built on foundational work from the Carazo Salas lab at the University of Bristol. We're working at the exciting intersection of cell biology, computer vision, engineering, and machine learning to industrialise next-generation science from research into the real world. Our mission is bold and ambitious and we have the best investors behind us from day 1. We're backed by venture capital firms who were the earliest investors in AI pioneer DeepMind, the two leading AI-first drug discovery companies, Exscientia and Recursion, and self-driving challenger Wayve. We're also supported by the founder/CEO of Abcam, which pioneered the antibody business.

Founded in 1946 in Nottingham, UK, Copley Scientific remains family owned and managed. We are recognised as the world's leading manufacturer of inhaler test equipment, in addition to being a trusted provider of test instrumentation for other pharmaceutical dosage forms including tablets, capsules, transdermals, semisolids, powders, suppositories and detergents. Copley continues to work closely with industry groups and leading experts to bring relevant new products to market, with all equipment backed by expert training and lifetime support. Committed to excellence, Copley aims to deliver exemplary service for an outstanding customer experience. With over 1,200 customers across 96 countries, including 9 of the world's 10 largest pharmaceutical companies, Copley prides itself on the highest quality products and service. It also remains true to its founding principle of meeting customer requirements through continuous innovation, over 75 years on. Visit www.copleyscientific.com for further information.

Providing predictive analytics from suspended-cells through our unbiased cytometry technology, AuraCyt™

DNAe is commercializing its pioneering semiconductor sequencing technology for healthcare applications where rapid point-of-need diagnostics are of critical need, including infectious disease and cancer testing and monitoring. It is developing the LiDia-SEQ™ system, a user-friendly, direct-from-specimen platform that performs genomic analysis on a microchip, to provide comprehensive, actionable information to clinicians in a matter of hours, versus days. DNAe’s initial focus is on infectious disease diagnostics, starting with a groundbreaking test for bloodstream infections (BSI) and antimicrobial resistance (AMR), which uses whole blood specimens to directly detect and identify infections that lead to sepsis. This will provide clinicians with actionable information to help select the appropriate antibiotics to treat the disease. A pipeline of follow-on tests is in development for viruses and cancer testing and monitoring. DNAe has received “Breakthrough Device” designation from the US Food and Drug Administration (FDA) for its pioneering platform and first assay. Headquartered in London, UK, DNAe has expanded operations further in with a clinical diagnostic development and manufacturing site in San Diego, CA. We are always on the lookout for exceptional talent. For more details, visit www.dnae.com. Or get in touch, we would love to hear from you. Twitter: @dna_electronics Instagram: dna.electronics

The NGX 124 is a compact, ultra-fast, sample-to-result molecular diagnostics platform that runs extracted nucleic acid (NA) or direct qPCR assays. It features a 4-channel thermal cycler with highly thermally conductive 96 well SBS format microtitre plates. An onboard automated heat sealer ensures consistent sealing. Plates shuttle between dual heater blocks in ~1 second, with fluorescence captured mid-transfer for real-time analysis. Each run processes 4–92 patient samples, plus 4 controls. Aspiration is via the Pathtube® a UN3373-compliant sample tube with a pierceable cap. Two versions exist: one for 1ml direct qPCR; the other for 200μl extracted NA. Reagent-mixing algorithms reduce dead volumes, cutting waste. Intuitive software allows operation by lab technicians, reducing reliance on BMSs and freeing them for more complex tasks. The unit occupies 0.7m², is mounted on wheels, and installs in under 15 minutes. Output includes CT values, raw data, and filtered/unfiltered curves. Fast MDx is also developing AI tools for early detection of infection hotspots. Each NGX 124 can scale to 3,000 tests per day (across 3 shifts), supporting pandemic preparedness. An Open Platform Unlike closed systems from major manufacturers, the CE IVDR and UKCA-marked NGX 124 is open. Labs can run their own LDTs or CE IVDd assays, driving innovation, reducing costs, and widening access to automated qPCR globally. Commercial Models 1. Subscription – Free platform, servicing and consumables included; labs pay per test with a monthly minimum. 2. Outright Purchase – Labs buy the platform and consumables, with optional service contract. Labs retain freedom to use existing assay suppliers. Launching in the UK and EU in September 2025. Our Mission Fast MDx is a registered Social Enterprise with the aim todemocratise molecular diagnostics. We welcome collaborations with academics, charities, and funders to develop early detection screening programs that can transform global healthcare.

Labocon is a renowned supplier of a wide range of Laboratory Equipment. The product range includes Analyzers, PCR products, General Laboratory Equipment like Mixers, Shakers, Temperature controlled Equipment, Balances & Microscopes etc. We provide as much information as possible about our products, and present them in simple and systematic way enabling the user to select the right product for their application conveniently. We make our client unperturbed by amending our products as per their needs. This is made achievable through our invincible staffs that constantly keep track of the research work going around the world. They are quite competent to add in the needs and refurbish the products. We are the one among the pinnacle to call upon for any requirement for your lab. Apart from this, our technical employees also work persistently on the automation of the products to help researchers in reaching their goal in a short time. We have laid our foundation over highest quality products with prompt & superior quality, after sales service and support.

Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics.

Nanothericsprovides products addressing the field of magnetic nanoparticle research and applications. In particular we aim to be the number one supplier of products for nanoparticle heating applications utilizing AC field and solenoid coil principles.

Nanovery is a biotechnology company founded in 2018 and based in Newcastle Helix, UK. The company specializes in nucleic acid nanorobotics, focusing on developing liquid nanorobot technology to advance nucleic acid research, particularly in RNA therapeutic analysis and biomarker quantification. Nanovery operates in the biotechnology sector, emphasizing research and development. The company's main offering is a proprietary platform that utilizes DNA nanorobotic sensors to quantify nucleic acid sequences in liquid samples. This platform simplifies the testing process by adding nanorobots to samples and measuring fluorescence to determine nucleic acid concentrations. Nanovery's technology supports RNA therapeutic development, biomarker analysis, and disease diagnostics, including early-stage detection. The integration of AI enhances data analysis and scalability, making the technology suitable for complex media. Nanovery has raised a total of $2.92 million in funding, with notable investors including Northstar Ventures and Innovate UK. The company aims to streamline testing protocols in biotech research, focusing on speed, cost-efficiency, and accuracy.

At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein Discovery™ system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology integrates cell-free protein synthesis and digital microfluidics on smart cartridges, allowing rapid progress on protein projects through a benchtop, automated, high-throughput protein access system. Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.

Ori Biotech is a London- and Philadelphia-based leader in CGT manufacturing technology that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, lifesaving treatments. By fully automating and standardizing CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing. So complex manufacturing challenges can be put where they belong – in the past.

PAA design and build laboratory automation systems, used within the fields of life and physical sciences, which allow integration with many different types of laboratory instruments to perform even the most complex experiments, interacting with numerous data sources. These systems are suited to the pharmaceutical, biotechnology and academic sectors. We provide a design and installation service to ensure you get the integrated lab automation solution you require to satisfy all aspects of your business.

Singer Instruments make laboratory automation to accelerate research for biologists who want to make the world a better place. Singer Instruments was established in 1934 and has a long-standing track record developing and manufacturing mechatronic workstations and laboratory automation robotics. Our world-leading, specialist products are used to facilitate and accelerate genetic and genomic research around the world. We supply public and private research institutions in multiple facets of biological sciences including Genetics, Neuroscience, Systems Biology, Cancer Biology, Biofuel Engineering and microbiology. Our headquarters, on the edge of Exmoor National Park in Somerset, England, is a state-of-the-art factory with full, virtual prototyping facilities, precision CNC manufacture and robotic coordinate measurement for quality control. We design, manufacture, program, assemble and QC all of our core products on site. As an employee-owned company, Singer puts their people first. Singer Instruments are very proud to have won the Somerset Business Awards Employer of the Year; By supporting our teams and investing in our people, we get the best results for our customers. Having worked alongside and added value to laboratory research for over 40 years, we are a truly integrated and respected member of the genetics research community. Our tag line ‘a responsibility to science’, acts as a continual reminder for us to do our utmost to support, develop new technology, and add as much value as possible to the science and the scientific community we serve. Should you have any feedback, suggestions or collaborative opportunities that may help accelerate scientific research, we would be delighted to hear from you.

SPT Labtech designs and makes products that transform the way scientists work. For over two decades, our expert scientists, engineers, and business innovators have created innovative solutions for liquid handling, sample preparation and management that help accelerate research and make a real difference to human health. We work collaboratively with our customers, building trusted relationships that enable us to deliver exceptional, personalized experiences designed for real world challenges in the lab. • Whether you operate on a nanolitre, microlitre or millilitre scale, our liquid handling solutions allow you to handle samples and reagents with accuracy and speed, across genomics, drug discovery and structural biology applications (firefly®, mosquito®, dragonfly®, apricot®) • Stay organized in the lab while saving valuable time and resources with our suite of automated sample management systems, including -80°C to ambient storage (comPOUND®, comPACT®, arktic®) and essential day-to-day tube management (BioMicroLab range, lab2lab) • Optimized cryo-EM sample and grid preparation is easy with chameleon® and Quantifoil, delivering consistently high-quality images and data.

Stratech Scientific Ltd. is a UK-based distributor of life science research tools, established in 1983 by Sue Hallett. The company specializes in overcoming logistical challenges related to temperature-sensitive biological products. With a revenue of $8.5 million and a team of approximately 20 employees, Stratech has built a reputation for reliability and customer-centric services, offering a money-back guarantee on all products. Stratech distributes over 90,000 life science research tools globally, including antibodies, molecular biology tools, sample preparation reagents, and specialized biochemicals. The company serves a diverse customer base, including academic, pharmaceutical, and biotechnology research laboratories. It has longstanding relationships with institutions like the John Innes Centre and supports manufacturers in entering European markets. Stratech is known for its expertise in cold-chain distribution and provides technical support tailored to various research applications.